Drug Enforcement Administration December 9, 2022 – Federal Register Recent Federal Regulation Documents

Schedules of Controlled Substances: Placement of Methiopropamine in Schedule I
Document Number: 2022-26805
Type: Rule
Date: 2022-12-09
Agency: Drug Enforcement Administration, Department of Justice
With the issuance of this final rule, the Drug Enforcement Administration places N-methyl-1-(thiophen-2-yl)propan-2-amine (methiopropamine), including its salts, isomers, and salts of isomers in schedule I of the Controlled Substances Act. This action is being taken to enable the United States to meet its obligations under the 1971 Convention on Psychotropic Substances. This action imposes the regulatory controls and administrative, civil, and criminal sanctions applicable to schedule I controlled substances on persons who handle (manufacture, distribute, reverse distribute, import, export, engage in research, conduct instructional activities or chemical analysis with, or possess) or propose to handle methiopropamine.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.